717-1109

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
717 (USA) · Dr. Reyes
consented 2014-01-27

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild CONFUSIONAL STATE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-20 (study day 25.0); relationship: REMOTE

mild assessed

Mild HYPERHIDROSIS — outcome: RECOVERED/RESOLVED; onset 2014-02-15 (study day 20.0); relationship: POSSIBLE

mild assessed

Mild INCREASED APPETITE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-29 (study day 3.0); relationship: REMOTE

mild assessed

Mild INCREASED APPETITE — outcome: RECOVERED/RESOLVED; onset 2014-01-29 (study day 3.0); relationship: REMOTE

mild assessed

Mild INSOMNIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-22 (study day 27.0); relationship: POSSIBLE

mild assessed

Mild PRURITUS GENERALISED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-04 (study day 37.0); relationship: PROBABLE

mild assessed

Mild SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-15 (study day 20.0); relationship: PROBABLE

mild assessed

Mild VENTRICULAR EXTRASYSTOLES — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-04-18 (study day 82.0); relationship: NONE

Data queries

No data queries.